CORONA REMEDIES
Back to Income Statement
|
CORONA REMEDIES Last 5 Year Appropriations History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | |
|---|---|---|---|---|
| Appropriations | ₹527 Cr | ₹3,963 Cr | ₹313 Cr | ₹313 Cr |
What is the latest Appropriations of CORONA REMEDIES ?
| Year | Appropriations |
|---|---|
| Mar2026 | ₹527 Cr |
| Mar2025 | ₹3,963 Cr |
| Mar2024 | ₹313 Cr |
| Mar2023 | ₹313 Cr |
How is Appropriations of CORONA REMEDIES Trending?
| Years | Appropriations | % Change | |
|---|---|---|---|
| Mar2026 | ₹527 Cr | -86.70 | |
| Mar2025 | ₹3,963 Cr | 1,165.26 | |
| Mar2024 | ₹313 Cr | 0.00 | |
| Mar2023 | ₹313 Cr | - | |
Compare Appropriations of peers of CORONA REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CORONA REMEDIES | ₹13,686.2 Cr | 7.7% | 5.9% | NA | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹441,958.0 Cr | -3% | -5.2% | 17.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹247,576.0 Cr | 0.2% | 9.7% | 56.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,233.0 Cr | 1.3% | 2% | 36.5% | Stock Analytics | |
| CIPLA | ₹110,273.0 Cr | -2.2% | -6.6% | -10.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,906.4 Cr | 1.4% | -3.7% | -8.8% | Stock Analytics | |
CORONA REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CORONA REMEDIES | 7.7% |
5.9% |
|
| SENSEX | -2.3% |
-4.1% |
-7.4% |
You may also like the below Video Courses